» Articles » PMID: 34806929

Alteration of Resting Electroencephalography by Acute Caffeine Consumption in Early Phase Psychosis

Overview
Publisher Sage Publications
Specialty Neurology
Date 2021 Nov 22
PMID 34806929
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Individuals with schizophrenia use twice as much caffeine on average when compared to healthy controls. Knowing the high rates of consumption, and the potential negative effects of such, it is important we understand the cortical mechanisms that underlie caffeine use, and the consequences of caffeine use on neural circuits in this population. Using a randomized, placebo controlled, double-blind, repeated measures design, the current study examines caffeine's effects on resting electroencephalography (EEG) power in those who have been recently diagnosed with schizophrenia (SZ) compared to regular-using healthy controls (HC). Correlations between average caffeine consumption, withdrawal symptoms, drug related symptoms and clinical psychosis symptoms were measured and significant correlations with neurophysiological data were examined. Results showed caffeine had no effect on alpha asymmetry in the SZ group, although caffeine produced a more global effect on the reduction of alpha power in the SZ group. Further, those with more positive symptoms were found to have a greater reduction in alpha power following caffeine administration. Caffeine also reduced beta power during eyes closed and eyes open resting in HC, but only during eyes closed resting conditions in the SZ group. These findings provide a descriptive profile of the resting EEG state following caffeine administration in individuals with schizophrenia. The findings ultimately suggest caffeine does not affect alpha or beta power as readily in this population and a higher dose may be needed to achieve the desired effects, which may elucidate motivational factors for high caffeine use.

Citing Articles

EEG Microstates in Early Phase Psychosis: The Effects of Acute Caffeine Consumption.

Bissonnette J, Anderson T, McKearney K, Tibbo P, Fisher D Clin EEG Neurosci. 2022; 53(4):335-343.

PMID: 35257622 PMC: 9174612. DOI: 10.1177/15500594221084994.


Sugars, Alcohol, and Caffeine Intake From Drinks Among Outpatients With Mental Health Disorders in Greece: A Pilot Study.

Apostolakopoulou X, Kontopoulou L, Karpetas G, Marakis G, Vasara E, Katsaras I Cureus. 2022; 14(1):e21563.

PMID: 35228922 PMC: 8873368. DOI: 10.7759/cureus.21563.

References
1.
Merrin E, Floyd T . Negative symptoms and EEG alpha activity in schizophrenic patients. Schizophr Res. 1992; 8(1):11-20. DOI: 10.1016/0920-9964(92)90056-b. View

2.
Jang K, Lee C, Lee S, Huh S, Chae J . Comparison of frontal alpha asymmetry among schizophrenia patients, major depressive disorder patients, and healthy controls. BMC Psychiatry. 2020; 20(1):586. PMC: 7727195. DOI: 10.1186/s12888-020-02972-8. View

3.
Siepmann M, Kirch W . Effects of caffeine on topographic quantitative EEG. Neuropsychobiology. 2002; 45(3):161-6. DOI: 10.1159/000054958. View

4.
Knott V, Raegele M, Fisher D, Robertson N, Millar A, McIntosh J . Clonidine pre-treatment fails to block acute smoking-induced EEG arousal/mood in cigarette smokers. Pharmacol Biochem Behav. 2005; 80(1):161-71. DOI: 10.1016/j.pbb.2004.10.025. View

5.
Miyauchi T, Tanaka K, Hagimoto H, Miura T, Kishimoto H, Matsushita M . Computerized EEG in schizophrenic patients. Biol Psychiatry. 1990; 28(6):488-94. DOI: 10.1016/0006-3223(90)90482-h. View